GKB Ophthalmics Limited (BOM:533212)
India · Delayed Price · Currency is INR 61.17
+6.02 (10.92%)
At close: Feb 13, 2026
GKB Ophthalmics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,503 | 1,090 | 882.54 | 754.75 | 709.38 | 568.78 |
Other Revenue | 4.43 | - | - | - | - | - |
| 1,507 | 1,090 | 882.54 | 754.75 | 709.38 | 568.78 | |
Revenue Growth (YoY) | 51.46% | 23.49% | 16.93% | 6.40% | 24.72% | -2.83% |
Cost of Revenue | 1,089 | 740.14 | 603.45 | 482.01 | 453.76 | 374.19 |
Gross Profit | 418.62 | 349.73 | 279.09 | 272.73 | 255.62 | 194.6 |
Selling, General & Admin | 205.15 | 201.46 | 162.23 | 132.94 | 111.53 | 80.25 |
Other Operating Expenses | 187.06 | 177.71 | 111.07 | 102.94 | 94.55 | 92.09 |
Operating Expenses | 424.56 | 410.04 | 302.29 | 264.17 | 232.76 | 203.77 |
Operating Income | -5.95 | -60.31 | -23.2 | 8.56 | 22.85 | -9.18 |
Interest Expense | -19.89 | -15.73 | -13.85 | -12.95 | -11.14 | -11.44 |
Interest & Investment Income | 10.75 | 10.75 | 8.89 | 6.02 | 5.12 | 2.28 |
Earnings From Equity Investments | -0.18 | 1.83 | -0.59 | 0.33 | 0.91 | 6.23 |
Currency Exchange Gain (Loss) | 1.92 | 1.92 | 0.16 | 1.27 | 2 | - |
Other Non Operating Income (Expenses) | -6.25 | -6.25 | -1.21 | -2.42 | -1.85 | -7.38 |
EBT Excluding Unusual Items | -19.6 | -67.79 | -29.79 | 0.81 | 17.9 | -19.5 |
Gain (Loss) on Sale of Investments | - | - | 0 | - | 0.07 | - |
Gain (Loss) on Sale of Assets | 0.4 | 0.4 | 0.45 | 0.57 | -0.42 | -2.92 |
Asset Writedown | - | - | - | - | - | -7.21 |
Other Unusual Items | 0.13 | 0.13 | 1.59 | 0 | 0.06 | 20.2 |
Pretax Income | -19.08 | -67.26 | -27.76 | 1.39 | 19.46 | -9.29 |
Income Tax Expense | 3.14 | 3.53 | 2.06 | 0.23 | 0.02 | -1.8 |
Earnings From Continuing Operations | -22.21 | -70.79 | -29.82 | 1.16 | 19.44 | -7.48 |
Minority Interest in Earnings | -3 | 0.34 | 1.72 | -2.84 | -6.7 | -1.59 |
Net Income | -25.21 | -70.45 | -28.11 | -1.67 | 12.74 | -9.08 |
Net Income to Common | -25.21 | -70.45 | -28.11 | -1.67 | 12.74 | -9.08 |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change (YoY) | 0.15% | - | - | - | 0.01% | - |
EPS (Basic) | -4.99 | -13.98 | -5.58 | -0.33 | 2.53 | -1.80 |
EPS (Diluted) | -5.00 | -13.98 | -5.58 | -0.33 | 2.53 | -1.80 |
Free Cash Flow | - | -55.77 | 21.44 | -39.87 | 3.11 | 5.23 |
Free Cash Flow Per Share | - | -11.06 | 4.25 | -7.91 | 0.62 | 1.04 |
Gross Margin | 27.77% | 32.09% | 31.62% | 36.14% | 36.03% | 34.21% |
Operating Margin | -0.39% | -5.53% | -2.63% | 1.13% | 3.22% | -1.61% |
Profit Margin | -1.67% | -6.46% | -3.19% | -0.22% | 1.80% | -1.60% |
Free Cash Flow Margin | - | -5.12% | 2.43% | -5.28% | 0.44% | 0.92% |
EBITDA | 26.33 | -29.45 | 5.78 | 36.83 | 49.52 | 22.22 |
EBITDA Margin | 1.75% | -2.70% | 0.66% | 4.88% | 6.98% | 3.91% |
D&A For EBITDA | 32.27 | 30.86 | 28.98 | 28.27 | 26.66 | 31.4 |
EBIT | -5.95 | -60.31 | -23.2 | 8.56 | 22.85 | -9.18 |
EBIT Margin | -0.39% | -5.53% | -2.63% | 1.13% | 3.22% | -1.61% |
Effective Tax Rate | - | - | - | 16.57% | 0.12% | - |
Revenue as Reported | 1,521 | 1,103 | 897.6 | 763.98 | 720.92 | 593.05 |
Advertising Expenses | - | 6.31 | 4.65 | 2.68 | 1.32 | 0.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.